Posted on 11/15/18
Exalenz Announces Third Quarter 2018 Financial Results
MODI’IN, Israel and MANASQUAN, N.J., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for . . .
Posted on 11/14/18
SCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company Update
SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today reported financial results for the quarter ended September 30, . . .
Posted on 11/13/18
FAIR Health Wins Four eHealthcare Leadership Awards for 2018
FAIR Health has won four eHealthcare Leadership Awards for 2018, as announced on November 7 at the Healthcare Internet Conference, sponsored by Greystone.Net, in Scottsdale, Arizona. . . .
Posted on 11/13/18
Dana-Farber Cancer Institute and Deerfield Collaborate
Dana-Farber Cancer Institute and Deerfield Management announced today an up to $80 million collaboration to create the Center for Protein Degradation at Dana-Farber. The goal of . . .
Posted on 11/13/18
Ferring Pharmaceuticals Enters Exclusive Agreement with INVO Bioscience
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today that it has signed an agreement to acquire from INVO Bioscience Inc. (OTCQB:IVOB) the exclusive U.S. commercialization rights for the . . .
Posted on 11/13/18
Eyenovia Reports Third Quarter 2018 Financial Results
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology . . .
Posted on 11/13/18
J&J Snack Foods Corp (JJSF) Q3 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.J&J Snack Foods Corp (NASDAQ:JJSF)Q3 2018 Earnings Conference CallNov. 09, 2018, 10:00 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorWelcome to the . . .
Posted on 11/13/18
Why Intercept Pharmaceuticals, Inc. Stock Broke Down in October
What happenedIntercept Pharmaceuticals (NASDAQ:ICPT), a mid-cap liver disease specialist, saw its shares sink by a whopping 24% last month, according to S&P Global Market Intelligence. What . . .
Posted on 11/13/18
Why Celgene's Stock Nosedived in October
What happenedShares of the blue-chip biotech giant Celgene Corp. (NASDAQ:CELG) sank by a worrisome 20.3% in October, according to S&P Global Market Intelligence. The good news, . . .
Posted on 11/13/18
Amneal Completes Transition Agreement With Lannett Company
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that it has completed a transition agreement with Lannett Company. Under the terms of the agreement, Amneal will take . . .
Posted on 11/13/18
Aetna Medicare HMO Plans in Pennsylvania Awarded High-Quality Rating
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna’s (NYSE: AET) Medicare Advantage Prescription Drug (MAPD) HMO plan serving the state of Pennsylvania has been awarded 4.5 stars out of 5 by . . .
Posted on 11/9/18
Soligenix Announces Recent Accomplishments And Third Quarter 2018 Financial Results
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 11/9/18
Intec Pharma Reports Third Quarter 2018 Financial Results and Corporate Update
Intec Pharma Ltd. (NASDAQ: NTEC) today announces financial results for the three and nine months ended September 30, 2018 and provides a corporate update.Highlights of the . . .
Posted on 11/9/18
Here's Why Celldex Therapeutics, Inc. Surged on Thursday
What happenedShares of Celldex Therapeutics, Inc. (NASDAQ:CLDX), a clinical-stage biotech developing novel new cancer therapies, rose 11.8% following the company's third-quarter earnings report on Thursday. Progress . . .
Posted on 11/9/18
MeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update
LONDON and NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results . . .
Posted on 11/8/18
Cambrex Reports Third Quarter 2018 Financial Results
EAST RUTHERFORD, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, and . . .
Posted on 11/8/18
Celgene: Money Will Flow Back
SummaryCelgene dipped to multi-year lows of $70.The major culprit was biotech sector weakness causing money to flow away.The net payout yield has surged to 17%, providing . . .
Posted on 11/8/18
Here's Why PTC Therapeutics Dropped 18% in October
What happenedShares of PTC Therapeutics (NASDAQ:PTCT) fell exactly 18% last month, according to data provided by S&P Global Market Intelligence. The development-stage biopharma stock took a . . .
Posted on 11/8/18
Celldex Provides Corporate Update and Reports Q3 2018 Results
HAMPTON, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2018.“We . . .
Posted on 11/8/18
Immunomedics Expands Clinical Collaboration With Astrazeneca
MORRIS PLAINS, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) , a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced . . .
Posted on 11/7/18
Bellerophon Provides Business Update and Reports Q3 2018 Financial Results
WARREN, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results . . .
Posted on 11/7/18
Amneal Announces Solid Third Quarter 2018 Financial Results
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its results today for the quarter ended September 30, 2018."The third quarter was defined by solid financial performance and strategic accomplishments . . .
Posted on 11/7/18
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system . . .
Posted on 11/7/18
Melinta Therapeutics Reports Third Quarter 2018 Financial Results
NEW HAVEN, Conn., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company, developing and commercializing novel antibiotics to treat serious bacterial . . .
Posted on 11/6/18
A&D Medical Partners with HRS
A&D Medical has partnered with Health Recovery Solutions (HRS) to bring the most cutting edge biometric monitoring equipment to patients using the HRS platform. A&D Medical . . .

